Baliospermum Montanum

Baliospermum Montanum

Product Name: Балиоспермум горный, Baliospermum montanum, Berg-Baliospermum, Baliospermo de montaña, Baliosperme de montagne, باليوسبرم الجبلي, บาลิโอสเปอร์มุม มอนทานัม, Baliospermum tog’, Baliospermum тоо өсүмдүгү, Dağ Baliospermumu, Балиспермуми кӯҳӣ, Kalninis Baliospermum, Kalnu Baliospermum, Баліоспермум гірський, הר בליוספרמום

Synonyms: Балиоспермум, Baliospermum, Berg-Rizinus, Falso ricino de montaña, Faux ricin de montagne, الخروع الكاذب الجبلي, ต้นละหุ่งเทียมภูเขา. Folk names: горный клещевинник, лесной клещевинник, краснокорень индийский, Danti (Sanskrit), Nagadanti (Ayurveda), Hill castor, Wild castor, ผักเสี้ยนป่า.

Used Parts: roots, rhizomes, leaves, seeds, stems, milky sap, wood, rhizomes.

Main Indications for Use of Baliospermum montanum: Hepatitis of viral etiology, cholestatic syndrome, parasitic liver infestations, chronic enteritis, functional diarrhea, urogenital trichomoniasis, dermatophytosis, atopic dermatitis, pruritus of unspecified etiology, skin ulcers, lymphadenitis, pyoderma, intestinal dysbiosis, acute bronchitis, intestinal helminthiasis, chronic colitis, obstructive jaundice, chronic prostatitis.

Use of Baliospermum montanum in Mixtures and Complexes: Alcoholic cirrhosis of the liver, human immunodeficiency virus, cutaneous vasculitis, secondary eczema, recurrent furunculosis, chronic tonsillitis, reactive pancreatitis, autoimmune thyroiditis, purulent sinusitis, osteomyelitis, nephropathy of toxic origin, ulcerative colitis, intestinal tuberculosis, irritable bowel syndrome, spastic constipation, seborrheic dermatitis.

Pharmacological Properties of Baliospermum montanum: hepatoprotective, anthelmintic, anti-inflammatory, antibacterial, skin-regenerating, laxative, wound-healing, immunomodulating, antioxidant, antiseptic, choleretic, fungicidal, analgesic, blood-purifying, antipruritic, anticarcinogenic, mucolytic.

Dosage of Pharmaceutical Forms — Baliospermum montanum

Powder — Baliospermum montanum

Indications (Powder): Hepatitis of viral etiology, chronic colitis, parasitic liver infestations, pruritus of unspecified etiology, lymphadenitis, dermatophytosis, pyoderma, chronic enteritis, skin ulcers.

Standard Dosage (Powder): 1.5 grams of powder once a day 20 minutes before meals, with warm water. Duration of intake — 14 days.

Enhanced Dosage (Powder): 2.0 grams twice a day for patients with acute skin pruritus, parasitic intestinal lesions, or pronounced lymphadenitis. Duration of intake — no more than 10 days.

Maximum Dosage (Powder): 2.5 grams three times a day for no more than 5 days in a row, used for exacerbation of intestinal helminthiasis, pyoderma, and ulcerative dermatoses. After 5 days — a mandatory break of at least 3 days.

Preventive Dosage (Powder): 1.0 gram once every 2 days for 30 days. Recommended for patients with chronic colitis, recurrent dermatitis, and chronic lymphadenitis. Used in adults with body weight from 50 to 90 kg.

Pediatric Dosage (Powder): Children over 7 years of age and weighing more than 25 kg — 0.5 grams once a day. For children under 7 years and body weight less than 25 kg, use is not recommended due to the lack of clinical database.

Contraindications (Powder): Gastric ulcer in the acute phase, hypersensitivity to plant components. Data on contraindications during pregnancy, lactation, and childhood under 7 years have not been scientifically registered.

Side Effects (Powder): When exceeding the dosage, nausea, pain in the epigastric region, and exacerbation of dermatitis may occur. In isolated cases — allergic rash.

Adjustment for Patient Body Weight: Patients with body weight below 60 kg are recommended to reduce the daily dosage by 20%. Patients with body weight over 90 kg are allowed to increase the dosage to 2.0 grams per day in the standard regimen.

Preparation Method (Powder): Ingredients per 100 grams of product: Roots of Baliospermum montanum — 100 grams. The roots are cleaned of coarse inclusions, washed under running water, dried in a drying chamber at a temperature of 45–50 °C for 48 hours. Then the raw material is ground to a powder state on a mill with metal grindstones. Sifted through a sieve with a mesh size of 0.5 mm. Packaged in airtight paper or glass containers.

Storage Conditions and Shelf Life (Powder): Store in a tightly closed package made of dark glass or multi-layer paper, at a temperature of +15 to +25 °C, away from direct sunlight and sources of electromagnetic radiation. Shelf life — 12 months. Use within 30 days after opening the package.

Dry Extract — Baliospermum montanum

Indications (Dry Extract): Hepatitis of viral etiology, chronic colitis, parasitic liver infestations, atopic dermatitis, acute bronchitis, urogenital trichomoniasis, dermatophytosis, skin ulcers.

Standard Dosage (Dry Extract): 250 milligrams of extract once a day on an empty stomach, with water at room temperature. Course duration — 10 days.

Enhanced Dosage (Dry Extract): 250 milligrams twice a day for active parasitic infestation, severe bronchitis, or pronounced skin inflammation with purulent elements. Course — no more than 7 days.

Maximum Dosage (Dry Extract): 500 milligrams three times a day, allowed for 3 days in a row for acute exacerbation of dermatological inflammations, recurrence of chronic trichomoniasis, and acute forms of colitis. A break of at least 5 days is required after the course.

Preventive Dosage (Dry Extract): 125 milligrams once every two days for 30 days. Recommended for chronic enteritis, hepatitis in remission, and a tendency to skin inflammations in adults with body weight from 50 to 90 kg.

Pediatric Dosage (Dry Extract): Children over 10 years of age and weighing more than 30 kg — 100 milligrams once a day. For children under 10 years, use is not recommended due to the lack of clinical data.

Contraindications (Dry Extract): Acute inflammatory processes in the stomach, individual intolerance. Data on contraindications during pregnancy, lactation, and childhood under 10 years have not been scientifically registered.

Side Effects (Dry Extract): When exceeding the dosage, nausea, abdominal pain, headache, and isolated cases of skin rash are possible.

Adjustment for Patient Body Weight: Patients with body weight below 60 kg are recommended to reduce the dosage by 25%. Patients with body weight over 90 kg are allowed to increase the dosage by 15% with standard intake.

Preparation Method (Dry Extract): Ingredients per 100 grams of finished extract: Roots of Baliospermum montanum — 500 grams, purified water — 1 liter. The ground roots are poured with water and infused for 12 hours. After that, they are extracted in a water bath at a temperature of 90 °C for 1 hour. The decoction is filtered and evaporated in a rotary evaporator to a thick extract. The thick extract is dried in a vacuum drying chamber at a temperature of 40 °C until a dry mass is formed. The resulting powder is sifted and packaged in airtight containers.

Storage Conditions and Shelf Life (Dry Extract): Store in a tightly closed container made of glass or pharmaceutical plastic, in a dry, light-protected place at a temperature of +10 to +25 °C. Shelf life — up to 18 months. Use within 20 days after opening.

Tincture — Baliospermum montanum

Indications (Tincture): Hepatitis of viral etiology, cholestatic syndrome, acute bronchitis, parasitic liver infestations, pruritus of unspecified etiology, chronic tonsillitis, lymphadenitis, pyoderma.

Standard Dosage (Tincture): 20 drops three times a day before meals, diluted in 50 ml of water. Course — 10 days.

Enhanced Dosage (Tincture): 30 drops three times a day for pronounced symptoms of obstructive jaundice, intense skin pruritus, and active pyodermatitis. Duration — no more than 5 days.

Maximum Dosage (Tincture): 40 drops four times a day for 3 days. Used exclusively for acute exacerbation of chronic lymphadenitis and the active phase of parasitic liver diseases. Liver function monitoring is required.

Preventive Dosage (Tincture): 15 drops once a day in the morning 30 minutes before meals. Course — 20 days. Used in adults with chronic liver diseases, chronic bronchitis, and a tendency to lymphatic edema.

Pediatric Dosage (Tincture): Children over 12 years of age and weighing more than 35 kg — 10 drops once a day, diluted in 50 ml of water. Not recommended for children under 12 years due to ethanol content.

Contraindications (Tincture): Alcoholism, epilepsy, organic brain lesions, severe forms of liver failure. Data on contraindications during pregnancy and lactation have not been scientifically registered, but due to ethanol content, use is not recommended.

Side Effects (Tincture): Dizziness, nausea, burning sensation in the stomach, in rare cases — headache and irritability when exceeding the dose.

Adjustment for Patient Body Weight: Patients with body weight less than 60 kg — reduce the dosage by 25%. For body weight over 90 kg, an increase in dosage to 35 drops three times a day in the standard regimen is allowed.

Preparation Method (Tincture): Ingredients per 100 milliliters of tincture: Dry roots of Baliospermum montanum — 25 grams, 70% ethanol — 100 milliliters. The roots are ground to a coarse fraction (at least 3 mm), poured with alcohol and infused in a sealed glass container in a dark place for 10 days at a temperature of 22–25 °C. Shaking daily. At the end, it is strained through gauze and filtered through a paper filter. Stored in a tightly closed container.

Storage Conditions and Shelf Life (Alcohol Tincture): Store in a dark, cool place at a temperature of +5 to +20 °C, away from sources of fire and direct sunlight. Shelf life — 24 months. After opening — use within 40 days.

Oil Infusion — Baliospermum montanum

Indications (Oil Infusion): Dermatophytosis, skin ulcers, atopic dermatitis, pyoderma, recurrent furunculosis, cutaneous vasculitis, seborrheic dermatitis, pruritus of unspecified etiology.

Standard Dosage (Oil Infusion): Externally apply to the affected skin areas in a thin layer 2 times a day — morning and evening. Distribute with light movements until absorbed. Course duration — from 7 to 14 days.

Enhanced Dosage (Oil Infusion): Apply 3 times a day to areas with pronounced inflammation or weeping in pyoderma, furunculosis, or vasculitis. Application of a soaked bandage overnight is possible. Course — no more than 10 days.

Maximum Dosage (Oil Infusion): Dense application under an occlusive dressing 2 times a day on limited skin areas (up to 5% of the body surface) for trophic ulcers, recurrent pseudofolliculitis, for no more than 5 days. Then transition to the standard regimen.

Preventive Dosage (Oil Infusion): Apply once a day to skin areas prone to irritation in patients with chronic atopic dermatitis, seasonal recurrence of seborrhea, or after insect bites. Apply in courses of 10 days with a 1-month break.

Pediatric Dosage (Oil Infusion): Applicable for children over 3 years of age. Apply once a day to limited areas (no more than 1% of the body surface) in a thin layer, without a bandage. Duration no more than 5 days. Do not use in children with body weight less than 15 kg.

Contraindications (Oil Infusion): Individual intolerance to components, acute purulent-necrotic skin lesions, open wounds. Data on contraindications during pregnancy and lactation have not been scientifically registered, but external use is allowed under supervision.

Side Effects (Oil Infusion): Rarely — burning sensation, skin redness, contact dermatitis with individual intolerance. With prolonged use, a folliculitis-like reaction is possible.

Adjustment for Patient Body Weight: Not required since the form is applied externally. However, for body weight below 30 kg, it is recommended to reduce the application area.

Preparation Method (Oil Infusion): Ingredients per 100 grams of finished product: dry ground roots of Baliospermum montanum — 20 grams; cold-pressed coconut oil — 100 grams. The roots are placed in a glass container and filled with oil. Infusion is carried out at a temperature of 50 °C in a water bath for 3 hours, then kept for another 24 hours at room temperature in a dark place. The mixture is strained through gauze, and the residue is squeezed out. The resulting infusion is filtered through a cotton-gauze filter and poured into sterile dark glass vials.

Storage Conditions and Shelf Life (Oil Infusion): Store in a tightly closed dark glass container at a temperature of +5 to +20 °C, away from sunlight and heating devices. Shelf life — 6 months. Use within 30 days after opening.

Cream — Baliospermum montanum

Indications (Cream): Atopic dermatitis, seborrheic dermatitis, secondary eczema, dermatophytosis, pruritus of unspecified etiology, chronic skin irritations, allergic skin reactions.

Standard Dosage (Cream): Apply once a day in the evening in a thin layer to affected or irritated skin areas. Gently rub until absorbed. Course — 7–10 days.

Enhanced Dosage (Cream): Apply 2 times a day for pronounced itching, peeling, hyperemia, and weeping. Particularly effective for recurrence of seborrheic dermatitis and exacerbation of eczema. Course duration — up to 10 days.

Maximum Dosage (Cream): Use up to 3 times a day on limited areas (up to 5 cm²) for severe skin inflammations, local exudation, and secondary bacterial infection. No more than 5 days in a row.

Preventive Dosage (Cream): Apply 2 times a week for 4 weeks to skin areas with increased sensitivity or a tendency to recurrent irritation. Recommended for seasonal exacerbation of dermatoses, in the interictal period in patients with allergic diathesis.

Pediatric Dosage (Cream): Permitted from 3 years of age. Use no more than once a day on small skin areas. Allowed for no more than 3 days in a row. Do not apply to the face and mucous membranes. Body weight — at least 15 kg.

Contraindications (Cream): Deep infected wounds, purulent skin inflammations, hypersensitivity to cream components. Data on contraindications during pregnancy and lactation have not been scientifically registered. External use is possible under specialist supervision.

Side Effects (Cream): Rarely — redness, burning sensation, peeling. In isolated cases — allergic contact dermatitis.

Adjustment for Patient Body Weight: For body weight less than 50 kg, it is recommended to limit the application area. For persons over 90 kg, application to wider areas is allowed without exceeding the daily frequency.

Preparation Method (Cream): Ingredients per 100 grams of cream: dry powder of Baliospermum montanum roots — 5 grams; coconut oil — 30 grams; glycerin — 10 grams; emulsifier (cetearyl alcohol + sodium stearate) — 8 grams; distilled water — 47 grams. In the oil phase, coconut oil and emulsifier are melted at a temperature of 60 °C. The aqueous phase is heated to 60 °C, glycerin and plant powder are dissolved, and thoroughly mixed. The phases are combined and intensively emulsified for 15 minutes. Cooled with constant stirring. Packaged in tubes or dark glass jars.

Storage Conditions and Shelf Life (Cream): Store in a dry, light-protected place at a temperature of +5 to +15 °C. Avoid heating. Shelf life — 6 months. Use within 20 days after opening the package.

Cosmetic Serum — Baliospermum montanum

Indications (Cosmetic Serum): Seborrheic dermatitis, atopic dermatitis, pruritus of unspecified etiology, post-inflammatory hyperpigmentation, chronic skin irritations, secondary eczema.

Standard Dosage (Cosmetic Serum): Apply once a day in the evening to pre-cleansed facial skin or local body areas (up to 5 drops per zone). Pat in with light tapping movements until absorbed. Course — 14 days.

Enhanced Dosage (Cosmetic Serum): Apply 2 times a day — morning and evening for pronounced itching, irritation, and peeling. Use until stabilization of the condition, but no more than 7 days in a row.

Maximum Dosage (Cosmetic Serum): Apply up to 3 times a day to areas with pronounced inflammation and hyperpigmentation. Allowed only for short-term use (up to 3 days) and under the supervision of a dermatologist.

Preventive Dosage (Cosmetic Serum): Apply once every 2 days in the evening for 30 days in the autumn-winter period. Applicable for patients with sensitive skin prone to irritation and seasonal inflammatory manifestations.

Pediatric Dosage (Cosmetic Serum): Use in children under 12 years is not recommended due to the high concentration of biologically active substances and possible irritant effect. For adolescents from 12 years — 1 drop once a day pointwise.

Contraindications (Cosmetic Serum): Pustular skin lesions, individual intolerance to plant extracts. No data on contraindications during pregnancy and lactation. When used in cosmetic doses, external application is allowed.

Side Effects (Cosmetic Serum): In case of overdose, redness, burning, and dry skin are possible. In rare cases — rash and contact dermatitis.

Adjustment for Patient Body Weight: Dose adjustment by body weight is not required since the form is intended for point or local external use.

Preparation Method (Cosmetic Serum): Ingredients per 100 grams of product: dry extract of Baliospermum montanum roots — 2 grams; lavender hydrolate — 60 grams; vegetable glycerin — 10 grams; low molecular weight hyaluronic acid — 0.5 grams; fractionated coconut base — 25 grams; potassium sorbate — 0.5 grams. The extract is introduced into a pre-heated mixture of hydrolate and glycerin (temperature not exceeding 40 °C), dissolved until complete homogenization. Then hyaluronic acid is added and thoroughly mixed. The coconut base and preservative are introduced. The mixture is shaken, filtered, and packaged in sterile dropper bottles.

Storage Conditions and Shelf Life (Cosmetic Serum): Store in the refrigerator at a temperature of +4 to +8 °C in a tightly closed frosted glass bottle. Do not allow direct sunlight. Shelf life — 3 months. Use within 20 days after opening.

Toxicity and Biosafety of Baliospermum montanum

Experimental studies to determine the acute toxicity of the alcohol extract of Baliospermum montanum roots in laboratory animals showed a relatively low level of toxicity. According to the study results, oral administration of the extract at doses up to 5000 mg/kg of body weight did not cause mortality in mice, which classifies the drug as practically non-toxic according to the Hodge and Sterner scale.

It is reported that the median lethal dose (LD₅₀) for the alcohol extract with oral administration to mice exceeds 5000 mg/kg, indicating a high level of biosafety when used correctly. However, when exceeding doses of more than 6000 mg/kg, symptoms of toxic irritation of the gastrointestinal tract were observed: diarrhea, decreased motor activity, and mild ataxia.

Chronic toxicity was not observed with course use at therapeutic doses. Immunohistochemical and biochemical parameters of the liver and kidneys remained within the physiological norm, which confirms the hepato- and nephrosafety of the plant in the concentrations used. Mutagenic and carcinogenic activity has not been established.

Reference: https://www.sciencedirect.com/...

Pharmacodynamics — Baliospermum montanum

The pharmacodynamic profile of Baliospermum montanum is determined by its rich phytochemical composition, which includes flavonoids, terpenes, diterpenoids, alkaloids, coumarins, phenolic compounds, and phytosteroids. These substances form multidirectional effects on key targets of the body — the immune system, skin, gastrointestinal tract, and liver. At the level of pharmacological effects, the plant exhibits pronounced antimicrobial, immunomodulating, anti-inflammatory, and antioxidant activity.

One of the key aspects of action is the modulation of cellular and humoral immunity. Studies have shown that plant extracts can activate macrophage phagocytic activity, stimulate the expression of interleukins (IL-1β, IL-6) and tumor necrosis factor-alpha (TNF-α), especially when acting on peripheral mononuclear cells. Such properties indicate a systemic immunomodulatory mechanism of action, realized through innate immune response receptors and pro-inflammatory cytokines.

From the perspective of skin pharmacological targets, the local effect of Baliospermum montanum bioflavonoids on the arachidonic acid cascade has been established — in particular, inhibition of the enzyme cyclooxygenase-2 (COX-2), which explains its anti-inflammatory effect at the skin level. This is accompanied by a decrease in local edema, redness, and expression of pro-inflammatory mediators. This effect is complemented by antioxidant activity due to phenolic compounds capable of neutralizing reactive oxygen species, stabilizing cell membranes, and reducing lipid peroxidation.

Within the framework of the effect on the digestive system, anthelmintic and laxative effects have been studied, which are realized through a direct toxic effect on the neuromuscular transmission of helminths, as well as a mild stimulating effect on the smooth muscles of the intestine. The biologically active substances of the roots can reduce spastic activity of the intestine and promote evacuation of contents without sharp stimulation of motility.

The hepatotropic effect deserves special attention. In experimental models of hepatotoxicity, the ability of Baliospermum montanum extracts to reduce transaminase levels (ALT, AST), stabilize biochemical parameters of bile metabolism, and enhance hepatocyte regeneration has been established. The proposed pharmacological target is the regulation of phase I and II detoxification enzymes, including glutathione-S-transferase and superoxide dismutase, which may explain the membrane-stabilizing and antioxidant effect at the systemic level.

Local effects of Baliospermum montanum are realized with external use due to a complex of biologically active resins and lipophilic compounds that have mild antiseptic, keratolytic, and skin-regenerating effects. The presence of phytosteroids and triterpenes causes stimulation of epithelial cell proliferation and restoration of the skin barrier.

At the neurohumoral level, plant extracts demonstrated a moderate sedative effect in preclinical trials, presumably realized through interaction with GABAergic receptors and a decrease in spontaneous motor activity. However, data on neuropharmacological targets remain limited and require further research.

Thus, the pharmacodynamics of Baliospermum montanum includes systemic and local anti-inflammatory, immunomodulating, antioxidant, hepatotropic, and mild sedative effects, realized through a wide range of biological targets — from pro-inflammatory mediators and enzyme systems to skin and intestinal receptors.

References:
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...
https://www.tandfonline.com/do...
https://www.worldscientific.co...

Pharmacokinetics — Baliospermum montanum

The pharmacokinetics of preparations based on Baliospermum montanum is determined by the structural nature of its constituent biologically active substances — mainly flavonoids, triterpenes, alkaloids, lipophilic fractions of resinous compounds, as well as phenolic acids and coumarins. Absorption depends on the dosage form and route of administration, including oral, transdermal, and mucosal.

With oral administration of preparations (powder, extract, tincture), the main fraction of active substances undergoes partial metabolic transformation already in the oral cavity and stomach. Flavonoids and terpenoids in hydrophilic form undergo active absorption in the small intestine with the participation of transport through the intestinal epithelium and interaction with microflora. Alkaloids and triterpenoids undergo enterohepatic circulation, partially metabolizing in the liver. The participation of microbiota in the hydrolysis of some glycoside fractions is assumed, which affects the kinetics of action of individual plant components.

With transdermal use (ointment, cream, oil infusion, serum), biologically active substances penetrate primarily through the lipid layers of the epidermis. An important role in this process is played by lipophilic terpenes and resinous components, which have the ability to accumulate in the upper layers of the skin and dermis, from where they can diffuse into the systemic bloodstream in small quantities. Local distribution is limited to the epidermis and hair follicles, with minimal systemic exposure.

Through mucous membranes (including the oral cavity, vagina, rectum), active components of extracts and infusions can penetrate into the systemic bloodstream bypassing first-pass hepatic metabolism. This provides a more direct pharmacological effect. This is especially true for alkaloid and phenolic fractions with high transmembrane permeability.

Metabolism occurs primarily in the liver with the participation of phase I and II enzyme systems, including hydroxylation, conjugation with glucuronic acid, and sulfation. Some components, in particular flavonoids, can induce or inhibit cytochrome P450 isoenzymes, which may be significant when combined with other substances. Alkaloids are partially metabolized in the kidneys, and resinous substances and lipophilic fractions can be deposited in adipose tissue with prolonged use.

Excretion is carried out by the kidneys in the form of polar metabolites (mainly conjugates), as well as through bile into the intestine. For lipophilic components, slow release through the skin and sebaceous glands is possible. Some of the terpene derivatives may be excreted through the lungs as volatile metabolites.

Thus, the pharmacokinetic behavior of Baliospermum montanum is characterized by a multi-channel absorption pathway, active metabolism in the liver and kidneys, and predominant excretion through the urinary and biliary systems, which requires consideration when selecting the form and frequency of administration.

References:
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://www.ncbi.nlm.nih.gov/p...
https://www.worldscientific.co...

Mechanisms of Action and Scientific Rationale — Baliospermum montanum

The mechanisms of action of Baliospermum montanum are associated with the activity of a group of biochemical compounds, including diterpenoids, triterpenes, phenolic acids, flavonoids, and alkaloids, identified in the roots and aerial parts of the plant. In vitro and in vivo studies have shown that these components participate in the regulation of key enzyme and receptor systems involved in inflammatory, redox, and immune processes.

One of the central pathways of action is the suppression of cyclooxygenase-2 (COX-2) enzyme expression, which leads to a decrease in the synthesis of prostaglandins responsible for the development of the inflammatory response. In parallel with this, modulation of the lipoxygenase pathway, including LOX-5, is observed, which additionally reduces the level of leukotrienes and decreases local inflammatory cascades. A decrease in myeloperoxidase activity in macrophages has also been confirmed, indicating suppression of reactive oxygen species and nitrite production.

At the level of intercellular signaling, modulation of NF-κB and MAPK signaling cascades has been recorded. Extracts of Baliospermum montanum inhibit the translocation of the p65 subunit of NF-κB into the nucleus, reducing the activation of genes encoding pro-inflammatory cytokines. This is accompanied by a decrease in the secretion of interleukin-6 (IL-6), interleukin-1β (IL-1β), and TNF-α in monocyte and macrophage cultures. In parallel, phosphorylation of ERK1/2 and p38 MAPK is suppressed, which limits the reactivity of innate immune cells.

There is evidence that terpenoids and flavonoids of Baliospermum montanum affect the activity of antioxidant enzymes, including superoxide dismutase (SOD), catalase, and glutathione peroxidase. This contributes to a decrease in the levels of malondialdehyde and other lipid peroxidation products, providing a membrane-stabilizing and cytoprotective effect.

A number of studies have shown the interaction of plant components with γ-aminobutyric acid (GABA) and glucocorticoid receptors, which may explain the moderate anxiolytic and sedative effect. The participation of ion channels regulating cell excitability, in particular chloride channels and voltage-gated calcium channels, is also possible.

A separate direction of mechanisms is associated with antiproliferative activity and induction of apoptosis in cell cultures. It has been established that bioactive fractions cause activation of caspase-3 and caspase-9, as well as a decrease in Bcl-2 expression with a simultaneous increase in Bax. This indicates the ability to induce the mitochondrial-dependent pathway of programmed cell death under conditions of cellular hyperreactivity.

Local mechanisms of action realized through the skin are associated with modulation of keratinocytes, a decrease in TLR-4 levels, and a decrease in the expression of IL-8 and other inflammatory mediators in epidermal cells. This ensures protection of the skin barrier and normalization of cellular proliferation under conditions of skin hyperreactivity.

Thus, Baliospermum montanum acts at multiple levels: from the regulation of inflammatory enzyme pathways and antioxidant defense to apoptotic activity and modulation of intercellular signaling. These effects are confirmed by biochemical and molecular studies, mainly at the preclinical level.

References:
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...
https://www.tandfonline.com/do...
https://www.worldscientific.co...
https://www.semanticscholar.or...

Synergy — Baliospermum montanum

Synergistic interactions of Baliospermum montanum with other medicinal plants and natural substances have been confirmed in a number of preclinical and pharmacological studies. The most pronounced forms of synergy are realized in combination with plants containing high concentrations of flavonoids, tannins, saponins, and terpenoids. Such combinations demonstrate potentiation of antioxidant, anti-inflammatory, and immunomodulating effects at the systemic and tissue-specific levels.

In in vivo experiments, it has been established that the combination of Baliospermum montanum extracts with flavonoid-containing plants, such as Phyllanthus niruri, leads to enhanced suppression of cyclooxygenase-2 and lipoxygenase-5 enzyme activity. The interaction mechanism is due to the cumulative inhibition of prostaglandin and leukotriene pathways, as well as cumulative suppression of NF-κB nuclear factor activation, which leads to an additive and partially potentiating anti-inflammatory effect.

Modulating interaction has been established in combination with extracts of Withania somnifera and Ocimum sanctum, due to the synchronous effect on the cytokine profile. Combined use leads to a balanced change in interleukin production (including IL-10, IL-6, and TNF-α), with an increase in macrophage phagocytic activity and stimulation of lymphocyte proliferation. This type of synergy is classified as functionally immunostimulating with a pronounced modulating component.

In studies of skin cell lines, synergy has been established between lipophilic extracts of Baliospermum montanum and curcumin. Combined use has an enhanced antioxidant effect due to active neutralization of free radicals, reduction of lipid peroxidation, and stabilization of mitochondrial membranes. The mechanism is realized through activation of the Nrf2 pathway and increased expression of endogenous antioxidant enzymes, including superoxide dismutase and glutathione peroxidase.

There is also evidence of synergistic action with saponin-containing plants (in particular, Bacopa monnieri and Centella asiatica), where enhancement of reparative and skin-regenerative effects is observed. Such interaction is accompanied by accelerated healing of skin integuments and restoration of the epidermal barrier function. In these combinations, overlap of action on epidermal growth factors and keratinocyte migration is assumed.

Of interest is the combination of Baliospermum montanum with natural resins and essential oils rich in mono- and sesquiterpenes. In such combinations, potentiation of antimicrobial activity against skin pathogens and fungal flora is observed. The mechanisms of interaction suggest synchronous destruction of microbial membranes, disruption of ion homeostasis, and inhibition of microbial enzymatic activity.

Thus, the synergy of Baliospermum montanum with various biologically active agents is realized both at the cellular and tissue levels, covering a wide range of targets: inflammatory mediators, antioxidant enzymes, immune cells, and the skin barrier. This makes it possible to create combined regimens with an enhanced pharmacological profile.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://www.tandfonline.com/do...
https://www.springer.com/gp/bo...
https://www.semanticscholar.or...

Geography of Use and Traditional Medicine — Baliospermum montanum

Baliospermum montanum is traditionally used in the ethnomedical systems of South and Southeast Asia, primarily in India, Nepal, Sri Lanka, Bhutan, Bangladesh, Thailand, and Myanmar. The plant is included in the registries of Ayurveda, used in the Siddha-Yogic and Unani medical traditions, and is also part of the folk healing practice of tribal peoples of Central and Eastern India, such as the Santals, Gonds, Bhils, and Garassia. In Thailand, the plant is known under folk names and is used in local phytotherapeutic practices of the northern provinces.

In the Ayurvedic system, Baliospermum montanum is known as "Danti" and belongs to the number of plants with pronounced cleansing properties. Its root is used in the form of powder and paste, as well as in complex formulations traditionally aimed at balancing the doshas. The milky sap of the plant, collected by cutting the roots or stem, is also widely used. In the traditions of the tribes of central India, the milky sap was used externally in the form of applications, as well as a component for ritual paints and protective patterns applied to the body during rituals.

In the folk medicine of India and Nepal, decoctions of the ground root were practiced, used as a universal remedy for cleansing the body. In some regions, there is a practice of mixing roots with other Ayurvedic components and applying to the skin in the form of a paste. The decoction was also used in steam procedures and wraps. Among the ethnic groups of Assam and Meghalaya, the roots were used as part of a traditional smoking mixture used in purification ceremonies.

In Thai traditional medicine, the plant was used in multi-phase tinctures, including in combination with ginger, pepper, and cassia bark. It was used in steaming and washing procedures, attaching importance not only to bodily but also to energetic cleansing. In the ritual practice of the peoples of the mountainous regions of Thailand, Baliospermum montanum root powder was part of protective mixtures that were burned in temple and home altars. It was believed that the smoke of these plants repels evil spirits and strengthens the strength of the spirit.

The historical depth of use can be traced to written mentions in ancient Ayurvedic treatises of the Gupta period (4th–6th centuries AD), where the plant is described as part of purification procedures. In medieval texts of Siddha medicine of southern India, there are also indications of the use of this plant in rejuvenating formulas. In Sri Lanka, Baliospermum montanum was included in medicinal oils intended for application to the body during ritual baths and massages.

In the ritual practice of some tribes of Eastern India, the roots of the plant were kept in homes as talismans. They were attributed the ability to "expel heat" and "drive away external influences." In folklore, it is mentioned as a "plant of transition," symbolizing purification during a change in the life cycle, including in initiation rites and farewell to the deceased.

Thus, Baliospermum montanum has a stable and diverse history of use in the folk, medical, and ritual culture of South and Southeast Asia, with many forms of administration and meanings — from healing to symbolic.